“…Research indicates that cancer survivors who have undergone chemotherapy report gait disturbances and higher incidences of falls (Bylow et al, 2008;Gewandter et al, 2013;Mohile et al, 2009Mohile et al, , 2011Stone et al, 2012;Wampler et al, 2007). Although the literature has not evaluated specific changes in spatiotemporal gait parameters in cancer patients, previous research indicates that individuals afflicted with peripheral neuropathy as a result of various etiologies will display altered gait patterns characterized by smaller step and stride lengths, wider step widths, increased double support times, and slower walking speeds (Dingwell & Cavanagh, 2001;Toulotte et al, 2006;Verghese et al, 2009;Wuehr et al, 2014). Furthermore, individuals with peripheral neuropathy will display increased variability within these same parameters, which is significant considering that increased variability is associated with increased falls (Dingwell & Cavanagh, 2001;Maki, EFFECTS OF CIPN ON GAIT AND FALL RISK 63 1997).…”